Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06296251

Dietary Supplementation on Body Fat Composition

A Randomized, Double-Blind, Placebo-Controlled, Three-Arm Parallel Study to Investigate the Effects of a Dietary Supplement Containing N-trans-Caffeoyltyramine (NCT) and N-trans-Feruloyltyramine (NFT) on Body Fat Composition

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Brightseed · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

The purpose of the current study is to examine the effects of a dietary supplement containing plant derived phenolics at two different dose levels in otherwise generally healthy adults with risk factors (high BMI at dyslipidemia and/or pre-diabetes) for body fat composition. The primary hypothesis is that supplementation with plant derived phenolics will decrease body fat composition compared to placebo.

Conditions

Interventions

TypeNameDescription
OTHERPlacebo treatmentMicrocrystaline cellulose (MCC)
DIETARY_SUPPLEMENTPlant derived phenolicsDietary supplement containing plant derived phenolics

Timeline

Start date
2024-04-18
Primary completion
2024-12-27
Completion
2025-02-27
First posted
2024-03-06
Last updated
2024-05-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06296251. Inclusion in this directory is not an endorsement.